Sign Out
Patients with hepatic coma or risk of hepatic coma. (Administration may enhance amino acid imbalance and hepatic coma may be worsened or induced.)
Patients with hyperammonemia. (Because of excess load of nitrogen, hyperammonemia may be worsened)
Patients with inherited abnormal amino acid metabolism. (Since the infused amino acids are not adequately metabolized, the patient's clinical condition may be worsened.)
Continue with Google